= 0.7731) with gold-standard ELISA measurements and accuracy in clinical risk stratification. These results highlight the potential of flow-enhanced E-AB sensors for continuous, near-real-time monitoring of critical biomarkers in clinical settings.
No takes yet. Share an insight, caveat, or question.
Chandran et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: